Barriers to Primary Care Physicians Prescribing Buprenorphine

• Published in: Annals of family medicine Vol. 12; no. 2; pp. 128 - 133
• Main Authors: Hutchinson, Eliza, Catlin, Mary, Andrilla, C. Holly A., Baldwin, Laura-Mae, Rosenblatt, Roger A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2014; American Academy of Family Physicians
• Subjects: Adult; Aged; Aged, 80 and over; buprenorphine; Buprenorphine - therapeutic use; Female; Humans; Internal Medicine; Male; Middle Aged; Narcotic Antagonists - therapeutic use; opiate addiction; opiate substitution treatment; Opioid-Related Disorders - drug therapy; Original Research; Practice Patterns, Physicians' - statistics & numerical data; Primary Health Care; rural health; Washington; Washington; opiate substitution treatment; primary health care; opiate addiction; buprenorphine; rural health
• DOI: 10.1370/afm.1595
• ISSN: 1544-1709; 1544-1717

Despite the efficacy of buprenorphine-naloxone for the treatment of opioid use disorders, few physicians in Washington State use this clinical tool. To address the acute need for this service, a Rural Opioid Addiction Management Project trained 120 Washington physicians in 2010-2011 to use buprenorphine. We conducted this study to determine what proportion of those trained physicians began prescribing this treatment and identify barriers to incorporating this approach into outpatient practice. We interviewed 92 of 120 physicians (77%), obtaining demographic information, current prescribing status, clinic characteristics, and barriers to prescribing buprenorphine. Residents and 7 physicians who were prescribing buprenorphine at the time of the course were excluded from the study. We analyzed the responses of the 78 remaining respondents. Almost all respondents reported positive attitudes toward buprenorphine, but only 22 (28%) reported prescribing buprenorphine. Most (95%, n = 21) new prescribers were family physicians. Physicians who prescribed buprenorphine were more likely to have partners who had received a waiver to prescribe buprenorphine. A lack of institutional support was associated with not prescribing the medication (P = .04). A lack of mental health and psychosocial support was the most frequently cited barrier by both those who prescribe and who do not prescribe buprenorphine. Interventions before and after training are needed to increase the number of physicians who offer buprenorphine for treatment of addiction. Targeting physicians in clinics that agree in advance to institute services, coupled with technical assistance after they have completed their training, their clinical teams, and their administrations is likely to help more physicians become active providers of this highly effective outpatient treatment.